Clinical Trial Update: Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study evaluating Copaxone in combination with minocycline for relapsing-remitting multiple sclerosis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)
• Minocycline (minocycline)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Relapse Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED